Skip to main content

DRESS syndrome: clinical myths and pearls.

Publication ,  Journal Article
Isaacs, M; Cardones, AR; Rahnama-Moghadam, S
Published in: Cutis
November 2018

Drug rash with eosinophilia and systemic symptoms (DRESS syndrome), also known as drug-induced hypersensitivity syndrome, is an uncommon severe systemic hypersensitivity drug reaction. It typically develops 2 to 6 weeks after exposure to a culprit medication and presents with widespread rash, facial edema, systemic symptoms (eg, fever, rigors, hypotension), lymphadenopathy, evidence of visceral organ involvement, and often eosinophilia. The clinical myths and pearls presented here highlight some of the commonly held assumptions regarding DRESS syndrome in an effort to illuminate subtleties of managing patients with this condition.

Duke Scholars

Published In

Cutis

EISSN

2326-6929

Publication Date

November 2018

Volume

102

Issue

5

Start / End Page

322 / 326

Location

United States

Related Subject Headings

  • Humans
  • Drug Hypersensitivity Syndrome
  • Dermatology & Venereal Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Isaacs, M., Cardones, A. R., & Rahnama-Moghadam, S. (2018). DRESS syndrome: clinical myths and pearls. Cutis, 102(5), 322–326.
Isaacs, Michael, Adela R. Cardones, and Sahand Rahnama-Moghadam. “DRESS syndrome: clinical myths and pearls.Cutis 102, no. 5 (November 2018): 322–26.
Isaacs M, Cardones AR, Rahnama-Moghadam S. DRESS syndrome: clinical myths and pearls. Cutis. 2018 Nov;102(5):322–6.
Isaacs, Michael, et al. “DRESS syndrome: clinical myths and pearls.Cutis, vol. 102, no. 5, Nov. 2018, pp. 322–26.
Isaacs M, Cardones AR, Rahnama-Moghadam S. DRESS syndrome: clinical myths and pearls. Cutis. 2018 Nov;102(5):322–326.

Published In

Cutis

EISSN

2326-6929

Publication Date

November 2018

Volume

102

Issue

5

Start / End Page

322 / 326

Location

United States

Related Subject Headings

  • Humans
  • Drug Hypersensitivity Syndrome
  • Dermatology & Venereal Diseases